Dr. Gyorki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
303 E 60th St
#8a
New York, NY 10022Phone+1 347-446-8589
Education & Training
University of Melbourne Faculty of MedicineClass of 2002
Publications & Presentations
PubMed
- Spoiled for Choice: Do We Finally Have Clarity on Optimal Treatment Sequencing for Patients with Metastatic Melanoma Harboring an Actionable BRAF Mutation?David E Gyorki
Annals of Surgical Oncology. 2022-04-16 - 3 citationsASO Author Reflections: Standardization in the Management of Retroperitoneal Sarcoma Through International Collaboration.David E. Gyorki, Christina L. Roland
Annals of Surgical Oncology. 2021-06-04 - 1 citationsSecond-line immunotherapy in patients with metastatic melanoma.Annie Wong, David E. Gyorki
The Lancet. Oncology. 2021-05-11
Press Mentions
‘Encouraging’ Data on Ipilimumab plus Anti-PD-1 in Metastatic MelanomaJune 1st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
